期刊文献+

慢性心力衰竭患者肾素-血管紧张素系统对纤溶功能的影响

Effect of renin-angiotens in system on fibrinolytic function in patients with chronic heart failure
下载PDF
导出
摘要 目的 研究慢性心力衰竭 (CHF)患者肾素血管紧张素系统 (RAS)和纤溶功能的变化 ,及RAS对纤溶功能的影响。方法 CHF患者 6 0例。健康体检者 2 0例 (正常对照组 )。用放射免疫法 (RIA)测定CHF组和对照组血浆肾素活性 (PRA)、血管紧张素Ⅱ (AngⅡ )、醛固酮 (ALD)水平 ,并用酶联免疫吸附法 (ELISA)测定血浆组织型纤溶酶原激活物 (t PA)、纤溶酶原激活物抑制物 1(PAI 1)抗原含量。结果 CHF组血浆PRA、AngⅡ、ALD、t PA和PAI 1平均水平都明显高于对照组 (P <0 .0 1)。CHF患者血浆PAI 1和AngⅡ水平增高程度随心力衰竭恶化而愈加明显。CHF患者血浆PAI 1抗原含量与AngⅡ水平呈正相关 (r=0 .994 ,P<0 .0 1)。 Objective To investigate the changes of renin-angiotensin system (RAS) and fibrinolytic function in patients with chronic heart failure (CHF), and to explore the effect of RAS on fibrinolytic function in patients with CHF. Methods Sixty patients with CHF were included in the CHF group, while 20 normal subjects were selected in the normal control (NC) group. The plasma levels of plasma renin activity (PRA), angiotensin Ⅱ (AngⅡ) and aldosterone (ALD) were measured in the CHF group and the NC group by radio immunoassay(RIA). The concentrations of plasma tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigen were simultaneously measured by enzyme-linked immunosorbent assay(ELISA). Results The mean levels of plasma PRA, AngⅡ, ALD, t-PA and PAI-1 in the CHF group were significantly higher than those in the NC group (P< 0.01). The more severe the heart failure was, the more marked increases were shown in the levels of plasma PAI-1 and AngⅡ in patients with CHF. There was a positive correlation between plasma PAI-1 antigen concentrations and AngⅡ levels in patients with CHF(r= 0.994, P< 0.01). Conclusion RAS might contribute to regulate the endogenous fibrinolytic function during the development of the CHF.
出处 《临床荟萃》 CAS 北大核心 2004年第5期258-261,共4页 Clinical Focus
关键词 心力衰竭 充血性 肾素-血管紧张素系统 纤溶酶原激活物抑制物-1 组织型纤溶酶原激活物 heart failure,congestive renin-angiotensin system plasminogen activator inhibitor-1 tissue plasminogen activator
  • 相关文献

参考文献5

二级参考文献24

  • 1胡小萍 李贺 等.大鼠高心输出量心衰时血浆RAAS、ET、ANP及尿NE的变化[J].中国病理生理杂志,1996,12:312-332.
  • 2[1]Catherin L,David E,Newby,et al.Fibrinolytic actions of intra-arterial angiotensin Ⅱ and bradykinin in vivo in man.Cardiov Res,2000,47:707-714.
  • 3[2]Douglas E,Vaughan jean L,Gean L,et al.Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction.Circulation, 1997,96:442-447.
  • 4[3]Chritopher R,Gibbs M,Andrew D,et al.Abnormalities of hemorheological endothelial and pulatelet in patients with chronic heart failure in sinus rhythm,Effects of angiotensin-converting enzyme inhibit and β-blocker therapy.Circulation,2001,103:1746-1751.
  • 5[4]Nicholas ER,Goodfield MB,David E,et al.Effect of acute angiotensin Ⅱ type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patient with heart failure.Circulation,1999,99:2983-2985.
  • 6[5]Douglas E,Vaughan S,Lazos,et al.Angiotensin Ⅱ regulates the rexpression of plasminogen activator inhibitor-1 in cultured endothelial cell.J Clin Invest,1995,95:995-1001.
  • 7[6]Ridker P,Cynthia L,Gaboury,et al.Stimulation of plasminogen activator inhinbitor in vivo by the fusion of angiotensin Ⅱ,Evidence of a potential interaction between the rennin-angiotensin system and fibrinolytic function.Circulation,1993,87:1969-1973.
  • 8[7]Nancy J,Brown MD,James V,et al.Bradykinin stimulates tissue plasminogen activator release from human forearm vasculatue through B2 recepto-dependent,NO synthase-independnt and cyclooxygenase-independent pathway.Circulation, 2000,102:2190-2196.
  • 9Vaughan D E, Lazos S A, Tong K. Angiotensin Ⅱ regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest, 1995,95:995--1001.
  • 10Itoh H, Mukoyama M, Pratt R E, et al. Multiple autocrine growth factors modulate vascular smooth muscle cells growth response to angiotensin Ⅱ. J Clin Invest,1993,91 : 2268--2274.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部